Scottish study hopes biomarkers can spot kidney rejection early

NCT ID NCT06830473

Recruiting now Knowledge-focused Sponsor: University of Edinburgh Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is tracking 200 kidney transplant patients in Scotland to see if certain biomarkers can help predict transplant rejection. Researchers will compare biomarker levels with standard biopsy results. The goal is to find a simpler, less invasive way to monitor transplant health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict and detect kidney transplant rejection earlier using simple biomarker tests.
What could go wrong: This is an observational study, not a treatment trial. It will not directly change patient care, and results may take years to influence clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY DISEASE, CHRONIC KIDNEY TRANSPLANT

Contacts and locations

Locations

Queen Elizabeth University Hospital
RECRUITING

Glasgow, G51 4TF, United Kingdom
Royal Infirmary of Edinburgh
RECRUITING

Edinburgh, EH16 4SU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.